ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 583,67
-0,64%
Dow Jones
40 820,46
1,51%
DAX
18 527,97
-0,39%
Brent Oil
83,565
-0,92%
Bitcoin
64 357,60
-0,76%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) Actualités

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateHeureSourceTitreSymboleSociété
05/10/202114h00Business WirePureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-BeingNASDAQ:PRTCPureTech Health PLC
29/09/202114h02Business WirePureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in JapanNASDAQ:PRTCPureTech Health PLC
20/09/202117h04Business WirePureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin ResistanceNASDAQ:PRTCPureTech Health PLC
14/09/202113h00Business WirePureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech SummitNASDAQ:PRTCPureTech Health PLC
10/09/202108h00Business WirePureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid LeukemiaNASDAQ:PRTCPureTech Health PLC
24/08/202112h56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
24/08/202108h00Business WirePureTech Health plc – Half-Year ReportNASDAQ:PRTCPureTech Health PLC
23/08/202113h00Business WirePureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021NASDAQ:PRTCPureTech Health PLC
17/08/202114h05Business WirePureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive ImpairmentsNASDAQ:PRTCPureTech Health PLC
13/08/202113h00Business WirePureTech Announces the Appointment Julie Krop, M.D., as Chief Medical OfficerNASDAQ:PRTCPureTech Health PLC
11/08/202113h00Business WirePureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain SyndromeNASDAQ:PRTCPureTech Health PLC
03/08/202108h00Business WirePureTech: Notice of Half-Yearly ResultsNASDAQ:PRTCPureTech Health PLC
22/07/202114h09Business WirePureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHDNASDAQ:PRTCPureTech Health PLC
21/07/202113h03Business WirePureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D FinancingNASDAQ:PRTCPureTech Health PLC
19/07/202113h02Business WirePureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special ...NASDAQ:PRTCPureTech Health PLC
09/07/202113h00Business WirePureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Tran...NASDAQ:PRTCPureTech Health PLC
08/07/202115h05Business WirePureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology...NASDAQ:PRTCPureTech Health PLC
07/07/202113h00Business WirePureTech Announces Clinical Trial & Supply Agreement with BeiGene to Evaluate LYT-200 & Tislelizumab in Patients with Difficu...NASDAQ:PRTCPureTech Health PLC
30/06/202113h00Business WirePureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory ...NASDAQ:PRTCPureTech Health PLC
29/06/202122h01Business WireVedanta Biosciences Presents New Data from Phase 1 Study of VE202, Its Rationally-Defined Consortium for the Treatment of Inf...NASDAQ:PRTCPureTech Health PLC
23/06/202114h46Business WirePureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety & Tolerability of Kar...NASDAQ:PRTCPureTech Health PLC
16/06/202113h00Business WirePureTech Acquires Remaining Interest in Founded Entity Alivio TherapeuticsNASDAQ:PRTCPureTech Health PLC
27/05/202119h32Business WireResults of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
27/05/202115h50Business WirePureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical En...NASDAQ:PRTCPureTech Health PLC
26/05/202114h05Business WirePureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital TherapeuticsNASDAQ:PRTCPureTech Health PLC
25/05/202113h00Business WirePureTech to Present at the Jefferies Virtual Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
12/05/202113h00Business WirePureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung DisordersNASDAQ:PRTCPureTech Health PLC
28/04/202117h13Business WirePureTech Announces Nature Publication Supporting Modulation of Meningeal Lymphatics to Target Alzheimer’s Disease PathologiesNASDAQ:PRTCPureTech Health PLC
26/04/202114h05Business WirePureTech Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane Wildman to Board of DirectorsNASDAQ:PRTCPureTech Health PLC
15/04/202114h36Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
CAP
Capgemini
EU
PX1
CAC 40
NASDAQ
AMZN
Amazon.com
EU
PX4
SBF 120
NYSE
KO
Coca Cola
EU
VK
Vallourec
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
MCD
McDonalds
USI
USTECH100
US Tech 100
EU
RNO
Renault
EU
AI
Air Liquide
SPI
SP500
S&P 500
NYSE
MRK
Merck
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés